CLINICAL_TRIALS
trial_result
· 2018-06-26
Clinical Trial Update: Intra-arterial Melphalan in Treating Younger Patients With Unilateral Retinoblastoma [Phase 1]
Summary
Phase 1 trial evaluating intra-arterial melphalan for unilateral retinoblastoma in younger patients has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Children's Oncology Group | Conditions: Unilateral Retinoblastoma | Phase 1 | Status: COMPLETED | Results posted: 2018-06-26